Dolores Schendel
Chief Tech/Sci/R&D Officer at MEDIGENE AG
Net worth: 1 M $ as of 2024-06-29
Network origin in Dolores Schendel first degree
Entity | Entity type | Industry | |
---|---|---|---|
19
| Public Company | Biotechnology | 19 |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Dolores Schendel via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Prudential Investment Corp.
Prudential Investment Corp. Investment ManagersFinance Part of Prudential Financial, Inc., Prudential Investment Corp. provides investment advice. The company is based in Grass Lake, MI. | Investment Managers | Director of Finance/CFO | |
4SC AG | Biotechnology | Investor Relations Contact | |
AC IMMUNE SA | Pharmaceuticals: Major | Investor Relations Contact | |
Burrill LLC
Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal | |
SOCIÉTÉ GÉNÉRALE | Regional Banks | Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree | |
BARCLAYS PLC | Investment Banks/Brokers | Director/Board Member | |
BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chief Executive Officer | |
3i Deutschland Gesellschaft für Industriebeteiligungen mbH
3i Deutschland Gesellschaft für Industriebeteiligungen mbH Investment ManagersFinance 3i Deutschland Gesellschaft für Industriebeteiligungen mbH (3i Deutschland) is the German private equity subsidiary of 3i Group Plc (LSE: III) in Great Britain. Established in Frankfurt in 1984, the firm invests in small and medium-sized German companies at all stages of development, from start-ups to established businesses. In addition to the Frankfurt office, 3i Deutschland has offices in Munich and Stuttgart. They drive their investment focus and decisions from their Frankfurt and Munich offices, and the team collaborates with Swiss colleagues in Zurich and 3i's network across Europe, Asia and the U.S. to invest in a wide range of industry sectors. | Investment Managers | Private Equity Investor | |
Imperial College London | College/University | Undergraduate Degree | |
Miltenyi GmbH
Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Financial Conglomerates | Corporate Officer/Principal | |
EPIGENOMICS AG | Medical Specialties | Chief Executive Officer | |
Bryan, Garnier & Co Ltd.
Bryan, Garnier & Co Ltd. Investment Banks/BrokersFinance Bryan, Garnier & Co Ltd. is a European, full-service growth-focused independent investment bank for technology, healthcare, consumer, and business services companies. The private company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company is well-positioned in a capex intensive industry that is increasingly dynamic both in capital raising and M & A, driven by the 4th Industrial Revolution. Bryan Garnier is the world's leading independent full-service investment bank for European healthcare and technology-led companies and their investors. The company is focused on new disruptive technologies and alternative production models in a variety of domains geared towards fighting climate change and environmental degradation. The consumer sector is transformed across its segments by the way digital natives relate to brands, products, and the environment. The company was founded in 1996 by Olivier Marie Paul Garnier de Falletans. | Investment Banks/Brokers | Analyst-Equity | |
Monash University
Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Doctorate Degree | |
BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | President Chief Executive Officer | |
Utah State University | College/University | Undergraduate Degree | |
University of Durham | College/University | Masters Business Admin | |
SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member | |
CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member | |
Allergan Ltd.
Allergan Ltd. Pharmaceuticals: MajorHealth Technology Allergan Ltd. provides eye care and specialty pharmaceutical products. It develops pharmaceutical products used for treatment of eye and skin care medications and neurological disorders. The firm develops products for glaucoma, dry eye, blepharospasm, cervical, dystonia, hemi-facial spasm, post-stroke spasticity and cerebral palsy. The company was founded in 1977 and is headquartered in Marlow, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Münster | College/University | Doctorate Degree | |
University of Innsbruck | College/University | Doctorate Degree | |
Technical University of Berlin | College/University | Doctorate Degree | |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Corporate Officer/Principal | |
PHARNEXT SCA | Biotechnology | Chief Tech/Sci/R&D Officer | |
H3 AEROSPACE GmbH & Co. KG
H3 AEROSPACE GmbH & Co. KG Aerospace & DefenseElectronic Technology H3 AEROSPACE GmbH & Co. KG engages in the acquisition, manufacture, marketing, leasing and sale of airplanes. The company was founded by Antoinette Hiebeler-Hasner in 2006 and is headquartered in Tussenhausen-Mattsies, Germany. | Aerospace & Defense | Founder | |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Zeus Capital Ltd. (Broker) | Investment Banks/Brokers | Analyst-Equity | |
Dr. Falk Pharma GmbH
Dr. Falk Pharma GmbH Medical/Nursing ServicesHealth Services Dr. Falk Pharma GmbH engages in the development and sale of medication for indications in hematology and gastroenterology in Germany and internationally. The company principally offers prescription drugs that are used in treating inflammatory bowel diseases, cholestatic liver diseases, irritable bowel syndromes, and constipation, as well as for colon cleansing prior to colonoscopies. It also organizes and sponsors medical education events; and offers publications for healthcare professionals, as well as for patients and their families. The company was formerly known as Dr. Falk Arzneimittel GmbH & Co KG and changed its name to Dr. Falk Pharma GmbH in 1989. Dr. Falk Pharma GmbH was founded in 1960 and is headquartered in Freiburg, Germany | Medical/Nursing Services | Chief Executive Officer | |
Helmholtz-Zentrum für Infektionsforschung GmbH
Helmholtz-Zentrum für Infektionsforschung GmbH BiotechnologyHealth Technology Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany. | Biotechnology | Director/Board Member | |
USC Marshall School of Business | College/University | Masters Business Admin | |
Catherex, Inc.
Catherex, Inc. Miscellaneous Commercial ServicesCommercial Services Catherex, Inc. provides medical research services. The company was founded by Michael A. Christini and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
DERMIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Chairman | |
Medigene Immunotherapies GmbH
Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Part of MediGene AG, Medigene Immunotherapies GmbH develops immunotherapy to treat cancer. The company is based in Planegg, Germany. The German company was founded in 2013 by Thomas Blankenstein, Dolores J. Schendel. The CEO is Axel-Sven Malkomes. Medigene Immunotherapies was acquired by MediGene AG on January 27, 2014 for $13.05 million. | Pharmaceuticals: Major | Chief Executive Officer | |
Scibase AB | Director/Board Member | ||
Memo Therapeutics AG
Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Director/Board Member | |
INFLARX N.V. | Biotechnology | Director of Finance/CFO | |
Kidpharma AG
Kidpharma AG Pharmaceuticals: MajorHealth Technology Kidpharma AG manufactures pharmaceutical products. The private company is based in Root, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Basilea Pharmaceutical International Ltd. | Chief Executive Officer | ||
Bluehaven Therapeutics AG | Chief Executive Officer | ||
CONNECT BIOPHARMA HOLDINGS LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
Germany | 18 |
United States | 10 |
United Kingdom | 9 |
Switzerland | 7 |
France | 4 |
Sectoral
Health Technology | 24 |
Finance | 12 |
Consumer Services | 11 |
Electronic Technology | 2 |
Health Services | 2 |
Operational
Director/Board Member | 46 |
Corporate Officer/Principal | 38 |
Chief Executive Officer | 24 |
Director of Finance/CFO | 21 |
Independent Dir/Board Member | 16 |
Most connected contacts
Insiders | |
---|---|
David Lemus | 22 |
Frank Mathias | 16 |
Thomas Taapken | 16 |
Peter Llewellyn-Davies | 14 |
Ernst-Ludwig Winnacker | 13 |
René Goedkoop | 12 |
Gerd Zettlmeissl | 11 |
Antoinette Hiebeler-Hasner | 10 |
Olav Zilian | 9 |
Gary Waanders | 8 |
Selwyn Ho | 8 |
Ronald Scott | 7 |
Axel-Sven Malkomes | 7 |
Kai Pinkernell | 6 |
Anthony Man | 3 |
- Stock Market
- Insiders
- Dolores Schendel
- Company connections